-
公开(公告)号:US20240327890A1
公开(公告)日:2024-10-03
申请号:US18741057
申请日:2024-06-12
CPC分类号: C12P21/005 , C07K16/00 , C12N1/38 , C07K2317/41
摘要: The present invention relates to methods for selecting between conditions which enhance cell growth or biomass generation and conditions which affect the N-glycosylation maturity of expressed glycoprotein produced by eukaryotic cells under fermentation culture conditions. Thus, in the methods of the present invention, the glycoprotein producing cells are cultured in a medium which is tailored to a desired end result. The invention also embraces the medium and the use thereof.
-
公开(公告)号:US12066428B2
公开(公告)日:2024-08-20
申请号:US17083589
申请日:2020-10-29
发明人: Xiaobo Wang , Yama A. Abassi , Nan Li , Lincoln Muir , Xiao Xu
CPC分类号: G01N33/5011 , C12N1/06 , C12N5/0693 , C12N7/00 , G01N27/021 , G01N33/5047 , C12N1/38
摘要: Methods of assessing cytolysis of cancer cells are provided, which include: providing a cell-substrate impedance monitoring device operably connected to an impedance analyzer, adding target cells characterized as cancer cells to a well of the device adding effector cells to the well to form a test well, where the effector cells are immune cells obtained or derived from a same patient as the target cells; monitoring cell-substrate impedance of the test well before and after adding the effector cells and optionally deriving an impedance-based parameter from the impedance; and determining effectiveness of effector cell killing of the target cells by comparing the impedance or impedance-based curves over time.
-
公开(公告)号:US12041938B2
公开(公告)日:2024-07-23
申请号:US17311771
申请日:2019-12-06
发明人: Youn-Sig Kwak , Da-Ran Kim
CPC分类号: A01N63/28 , A01N33/08 , C12N1/205 , C12N1/38 , C12R2001/465
摘要: A method for controlling a plant disease according to an embodiment includes treating a plant part, a seed, or a soil with a composition including at least one amino acid selected from the group consisting of glutamic acid, proline, tryptophan, and a combination thereof as an effective component. A method for promoting growth of an effective microorganism or controlling a plant disease uses prebiotics. As the amino acids have an effect of significantly promoting the growth of effective microorganism and having sustained maintenance of the effective microorganism at the same time and can reduce the incidence rate of plant disease, they can enhance the usefulness of eco-friendly microbial strains for disease control and be advantageously used as a substitute for chemical control agents.
-
公开(公告)号:US20240156886A1
公开(公告)日:2024-05-16
申请号:US18549669
申请日:2022-03-11
IPC分类号: A61K35/747 , C12N1/20 , C12N1/38 , C12R1/23
CPC分类号: A61K35/747 , C12N1/20 , C12N1/38 , C12N2500/34 , C12R2001/23
摘要: The invention herein relates generally to enhancing the survival and activity of probiotic Lactobacillus strains in mammals. Lactobacillus strain comprising a LacS transporter sequence having a sequence identity of at least 70% to SEQ ID NO: 1, and/or comprising a GH42 B-gal sequence, wherein the Lactobacillus strain is not a Lactobacillus reuteri strain. The invention comprises methods for cultivating and manufacturing probiotic Lactobacillus strains, and products containing such strains. In more detail the GC present invention relates to a composition comprising probiotic Lactobacillus strains, obtained by a step of growing the bacteria in a medium comprising galacto-oligosaccharides (GOS) (“pre-conditioning”), and administering said pre-conditioned bacteria together with GOS in the final product. The inventors have found that such method induces a boost in the beneficial effects of the probiotic bacteria, such as survival in the gastrointestinal tract.
-
公开(公告)号:US20240076697A1
公开(公告)日:2024-03-07
申请号:US18240550
申请日:2023-08-31
申请人: Inscripta, Inc.
发明人: Karl GERHARDT , Charles JOHNSON , Martha BRAUN
CPC分类号: C12N15/902 , C12N1/20 , C12N1/38 , C12N9/22 , C12N15/11 , C12N15/70 , C12N2310/20 , C12N2800/101 , C12N2800/80 , C12N2830/002
摘要: The present disclosure provides compositions of matter, methods, systems, and instruments for improved nucleic acid-guided nuclease editing in live cells, wherein the live cells are shifted into a growth-arrested state for editing.
-
6.
公开(公告)号:US11889846B2
公开(公告)日:2024-02-06
申请号:US17521236
申请日:2021-11-08
申请人: MEIJI CO., LTD.
发明人: Hanae Tsuchihashi , Eri Yamamoto , Yoshitaka Kawai , Mizue Saito , Mariko Takeda , Ayumi Ichikawa , Atsuko Ueno
CPC分类号: A23C9/1234 , C12N15/01 , C12N1/205 , C12R2001/225
摘要: The present invention provides a lactic acid bacteria-containing composition comprising a Lactobacillus delbrueckii and a Streptococcus thermophilus.
-
7.
公开(公告)号:US20230287321A1
公开(公告)日:2023-09-14
申请号:US17966579
申请日:2022-10-14
申请人: DRYLET, INC.
发明人: M. Scott CONLEY , Mark MENENDEZ
CPC分类号: C12M25/16 , C02F3/107 , C02F3/108 , C02F3/348 , C12M21/12 , C12M41/12 , C12M41/40 , C12N1/38 , C12N11/14
摘要: Disclosed herein are systems and methods that provide for increased carrying capacity of bioreactors using silica polymers. Disclosed is a method that includes supplying nutrients and silica polymers containing microorganisms to a bioreactor to form a first suspension and controlling temperature, pressure, and nutrient conditions in the bioreactor to produce a second suspension with increased carrying capacity as compared to a control bioreactor containing microorganisms without the silica polymers.
-
公开(公告)号:US20230123785A1
公开(公告)日:2023-04-20
申请号:US18072800
申请日:2022-12-01
发明人: Mohammad R. SEYEDSAYAMDOST , Fei XU , Yihan WU , Leah BUSHIN , Katherine Davis
摘要: Microorganisms are prolific producers of natural products, a group of molecules that make up the majority of drugs approved by the FDA in the past 35 years. After decades of mining, the low-hanging fruit has been picked and so discovery of drug-like molecules from microorganisms has come to a near-halt. The reason for this lack of productivity is that most biosynthetic pathways that give rise to natural products are not active under typical laboratory growth conditions. These so-called ‘cryptic’ or ‘silent’ pathways are a major source of new bioactive molecules and methods that reliably activate them could have a profound impact on drug discovery. Disclosed herein is a rapid genetics-free method for eliciting and detecting cryptic metabolites using an imaging mass spectrometry-based approach. An organism of choice is challenged with elicitors from a small molecule library. The molecules elicited are then imaged by mass spec, which allows for rapid identification of cryptic metabolites. These are then isolated and characterized. Employing the disclosed approach activated production of cryptic glycopeptides from an actinomycete bacterium. The molecules that result, the keratinimicins and keratinicyclins, are metabolites with important structural features. At least two of these, keratinimicins B and C, are highly bioactive against several pathogenic strains. This approach will allow for rapid activation and identification of cryptic metabolites from diverse microorganisms in the future.
-
公开(公告)号:US20230091009A1
公开(公告)日:2023-03-23
申请号:US17896103
申请日:2022-08-26
发明人: LU LU , Yongjie Yu , Ruijie Yang
摘要: The present invention relates to a method for promoting growth of gas-fermented microorganisms, comprising the following steps: S1. ultrasonically blending a surfactant and a culture medium, then adding a fluorine-containing alkyl compound to a mixture, and ultrasonically processing the mixture to obtain a perfluorocarbon nanoemulsion; S2. inoculating a bacterial suspension into the perfluorocarbon nanoemulsion, and introducing simultaneously a mixed gas to obtain a precursor; S3. cultivating the precursor in a shaker, wherein the precursor has a diameter of bubbles of 2.0-4.2 mm, and the bubbles have the total volume of less than 40 ml. Under these conditions, the microorganisms have a high utilization rate of the gas, can grow and metabolize more quickly, and can obtain bacteria and products more quickly. Compared with a traditional culture system, addition of a mass transfer material can promote gas mass transfer. Therefore, the gas consumption is small, and the cost is low.
-
公开(公告)号:US11427800B2
公开(公告)日:2022-08-30
申请号:US16227371
申请日:2018-12-20
申请人: Syngulon SA
发明人: Philippe Gabant
IPC分类号: C12N1/12 , A61K36/06 , A61K35/74 , A61K36/02 , C12N1/16 , C12N1/20 , C07K14/195 , C12N1/38 , A01N63/50
摘要: It can be useful to regulate the growth of microbial cells. Some embodiments herein provide genetically engineered microbial cells that can produce bacteriocins to control the growth of microbial cells. In some embodiments, microbial cells are contained within a desired environment. In some embodiments, contaminating microbial cells are neutralized. In some embodiments, a first microbial cell type regulates the growth of a second microbial cell type so as to maintain a desired ratio of the two cell types.
-
-
-
-
-
-
-
-
-